ODESIVIMAB
UNII UY9LQ8P6HW

Substance Identification & Data

This profile provides standardized clinical and technical data for Odesivimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) UY9LQ8P6HW.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2135632-30-1 and the RxNorm Concept ID (RxCUI) 2461340. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
UY9LQ8P6HW
CAS Registry Number
2135632-30-1
RxNorm Concept ID

Detailed Substance Profile

Preferred Name
ODESIVIMAB
Official standardized name for this substance within the FDA UNII nomenclature system.
Molecular Formula
UY9LQ8P6HW
The specific atomic composition represented as a molecular structure string.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
11033
Sequential identifier assigned via the WHO International Nonproprietary Name program.
USAN ID
FG-102
Identifier assigned by the United States Adopted Names Council.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Odesivimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ODESIVIMAB
ODESIVIMAB-EBGN

Common Names & Synonyms

ODESIVIMAB [INN]
ODESIVIMAB [USAN]
ODESIVIMAB [WHO-DD]
ODESIVIMAB EBGN [WHO-DD]
REGN-EB3 COMPONENT ODESIVIMAB

Brand / Trade Names

INMAZEB COMPONENT ODESIVIMAB-EBGN

Technical Codes

REGN3471
REGN-3471

NDC Products Containing ODESIVIMAB

This unique ingredient identifier is listed as an ingredient or substance in the following products in the NDC directory: